Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Pavan

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Critical Reviews in Oncology/Hematology|October 26, 2017
Combination immunotherapy strategies in advanced non-small cell lung cancer (NSCLC): Does biological rationale meet clinical needs?Ilaria Attili, Antonio Passaro, Alberto Pavan, et al.
International Journal of Molecular Sciences|April 19, 2019
LKB1 and Tumor Metabolism: The Interplay of Immune and Angiogenic Microenvironment in Lung CancerLaura Bonanno, Elisabetta Zulato, Alberto Pavan, et al.
Cancer Treatment Reviews|May 24, 2020
Real world data in the era of Immune Checkpoint Inhibitors (ICIs): Increasing evidence and future applications in lung cancerGiulia Pasello, Alberto Pavan, Ilaria Attili, et al.
Critical Reviews in Oncology/Hematology|June 4, 2021
Treatment strategies for locally advanced non-small cell lung cancer in elderly patients: Translating scientific evidence into clinical practiceLaura Bonanno, Ilaria Attili, Alberto Pavan, et al.
Frontiers in Medicine|June 28, 2021
Subacute Cutaneous Lupus Erythematosus-Like Eruption Induced by EGFR -Tyrosine Kinase Inhibitor in <i>EGFR</i>-Mutated Non-small Cell Lung Cancer: A Case ReportAlessandra Ferro, Angela Filoni, Alberto Pavan, et al.
International Journal of Molecular Sciences|December 22, 2019
Detection of Loss of Heterozygosity in cfDNA of Advanced <i>EGFR</i>- or <i>KRAS</i>-Mutated Non-Small-Cell Lung Cancer PatientsElisa Boldrin, Giorgia Nardo, Elisabetta Zulato, et al.
Journal of Clinical Medicine|March 17, 2025
Real-Life Comparison of Diagnostic Yield and Sample Adequacy of 22 G and 25 G EBUS-TBNB Needles: A Retrospective StudyFilippo Lanfranchi, George Kalak, Gioele Castelli, et al.
The Oncologist|June 20, 2020
Clinical Impact of Plasma and Tissue Next-Generation Sequencing in Advanced Non-Small Cell Lung Cancer: A Real-World ExperienceLaura Bonanno, Alberto Pavan, Alessandra Ferro, et al.
British Journal of Cancer|March 10, 2022
Liquid biopsy and non-small cell lung cancer: are we looking at the tip of the iceberg?Laura Bonanno, Alessandro Dal Maso, Alberto Pavan, et al.
Frontiers in Oncology|July 24, 2024
Immune-related adverse events in patients treated with immunotherapy for locally advanced or metastatic NSCLC in real-world settings: a systematic review and meta-analysisGiulia Pasello, Alberto Pavan, Mattia De Nuzzo, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Critical Reviews in Oncology/Hematology|October 26, 2017
Combination immunotherapy strategies in advanced non-small cell lung cancer (NSCLC): Does biological rationale meet clinical needs?Ilaria Attili, Antonio Passaro, Alberto Pavan, et al.
International Journal of Molecular Sciences|April 19, 2019
LKB1 and Tumor Metabolism: The Interplay of Immune and Angiogenic Microenvironment in Lung CancerLaura Bonanno, Elisabetta Zulato, Alberto Pavan, et al.
Cancer Treatment Reviews|May 24, 2020
Real world data in the era of Immune Checkpoint Inhibitors (ICIs): Increasing evidence and future applications in lung cancerGiulia Pasello, Alberto Pavan, Ilaria Attili, et al.
Critical Reviews in Oncology/Hematology|June 4, 2021
Treatment strategies for locally advanced non-small cell lung cancer in elderly patients: Translating scientific evidence into clinical practiceLaura Bonanno, Ilaria Attili, Alberto Pavan, et al.
Frontiers in Medicine|June 28, 2021
Subacute Cutaneous Lupus Erythematosus-Like Eruption Induced by EGFR -Tyrosine Kinase Inhibitor in <i>EGFR</i>-Mutated Non-small Cell Lung Cancer: A Case ReportAlessandra Ferro, Angela Filoni, Alberto Pavan, et al.
International Journal of Molecular Sciences|December 22, 2019
Detection of Loss of Heterozygosity in cfDNA of Advanced <i>EGFR</i>- or <i>KRAS</i>-Mutated Non-Small-Cell Lung Cancer PatientsElisa Boldrin, Giorgia Nardo, Elisabetta Zulato, et al.
Journal of Clinical Medicine|March 17, 2025
Real-Life Comparison of Diagnostic Yield and Sample Adequacy of 22 G and 25 G EBUS-TBNB Needles: A Retrospective StudyFilippo Lanfranchi, George Kalak, Gioele Castelli, et al.
The Oncologist|June 20, 2020
Clinical Impact of Plasma and Tissue Next-Generation Sequencing in Advanced Non-Small Cell Lung Cancer: A Real-World ExperienceLaura Bonanno, Alberto Pavan, Alessandra Ferro, et al.
British Journal of Cancer|March 10, 2022
Liquid biopsy and non-small cell lung cancer: are we looking at the tip of the iceberg?Laura Bonanno, Alessandro Dal Maso, Alberto Pavan, et al.
Frontiers in Oncology|July 24, 2024
Immune-related adverse events in patients treated with immunotherapy for locally advanced or metastatic NSCLC in real-world settings: a systematic review and meta-analysisGiulia Pasello, Alberto Pavan, Mattia De Nuzzo, et al.
Pageof 4